Interventional technology developer Boston Scientific has launched its Expect 19 Flex endoscopic ultrasound aspiration needle.
Designed for acquiring tissue samples under endoscopic ultrasound guidance for diagnosing cancer in organs adjacent to the gastrointestinal tract, Expect 19 Flex's nitinol construction offers improved flexibility compared to existing endoscopic ultrasound fine-needle aspiration (FNA) devices. It also features a large diameter for expanded diagnostic capabilities, Boston Scientific said.
